US FDA approves emergency use for Johnson & Johnson corona vaccine... 3rd vaccine

The U.S. Food and Drug Administration's FDA approved emergency use of the drug company Johnson & Johnson's (J&J) COVID-19 vaccine, the AP-AFP news agency reported.

The FDA accepted within one day that the advisory body, the Vaccine and Biological Drugs Advisory Committee, recommended by voting to approve emergency use of J&J's COVID-19 vaccine.

The Advisory Committee unanimously recommended that J&J's vaccine be approved for urgent use in adult Americans over 18 years of age.

As a result, the United States has secured a third COVID-19 vaccine available to Americans, following the vaccines of Pfizer-Bioentech and Modena.